TEI
TEMPLETON EMERGING MARKETS INCOME FUNDMarquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors | Q4 2025 | Q1 2026 | → $6.81 | +17% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at TEMPLETON EMERGING MARKETS INCOME FUND. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Sep 4, 2018 — the most recent Form 4 on file — not from today.
- Form 40001510281-18-000061Sep 4, 2018
- Form 40001510281-18-000060Aug 30, 2018
- Form 40001510281-18-000059Aug 28, 2018
- Form 40001510281-18-000058Aug 24, 2018
- Form 40001510281-18-000057Aug 22, 2018
- Form 40001510281-18-000056Aug 17, 2018
- Form 40001510281-18-000055Aug 15, 2018
- Form 40001510281-18-000054Aug 13, 2018
- Form 40001510281-18-000053Aug 9, 2018
- Form 40001510281-18-000052Aug 7, 2018
- Form 40001510281-18-000051Aug 3, 2018
- Form 40001510281-18-000050Aug 1, 2018
- Form 40001510281-18-000049Jul 30, 2018
- Form 40001510281-18-000048Jul 26, 2018
- Form 40001510281-18-000047Jul 24, 2018
Fundamentals
XBRL · TEMPLETON EMERGING MARKETS INCOME FUNDNot enough XBRL history to plot. TEMPLETON EMERGING MARKETS INCOME FUNDhasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for TEMPLETON EMERGING MARKETS INCOME FUND — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- DEF 14AProxy statementMar 31, 2026
- DEF 14AProxy statementApr 1, 2025
- DEF 14AProxy statementApr 2, 2024
- SC 13G/A5%+ ownership (amended)Feb 14, 2024
- SC 13G/AAMENDED SCHEDULE 13GJan 17, 2024
- DEF 14ADEF14AMar 27, 2023
- SC 13G5%+ ownership (passive)Feb 14, 2023
- SC 13G/AAMENDED SCHEDULE 13GJan 23, 2023
- SC 13G/AAMENDED SCHEDULE 13GOct 6, 2022
- DEF 14AProxy statementMar 28, 2022
- SC 13G/AAMENDED SCHEDULE 13GJan 12, 2022
- DEF 14AProxy statementMar 29, 2021
- SC 13G5%+ ownership (passive)Feb 16, 2021
- SC 13G/AAMENDED SCHEDULE 13GFeb 1, 2021
- DEF 14AProxy statementMar 30, 2020
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q4 2025 | Q1 2026 | $5.84 | $6.81 | +17% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.